FGF7P6: A Potential Drug Target and Biomarker (G387628)

Target Name: FGF7P6

NCBI ID: G387628

FGF7P6

Other Name(s): fibroblast growth factor 7 pseudogene 6 | FGF7P6 variant 1 | Fibroblast growth factor 7 pseudogene 6, transcript variant 1 | KGFLP1

FGF7P6: A Potential Drug Target and Biomarker

Fibroblast growth factor 7 (FGF7) is a transmembrane protein that plays a crucial role in cell proliferation, growth, and survival. It is a potent regulator of cell fate, and its abnormal expression has been implicated in numerous diseases, including cancer, neurodegenerative diseases , and developmental disorders. The FGF7 gene has four pseudogenes, FGF7P6, FGF7P7, FGF7P8, and FGF7P9, which encode the full-length protein.

In recent years, significant research has focused on the characterization of these pseudogenes, with a particular focus on FGF7P6. FGF7P6 has been shown to be a key regulator of cell proliferation, differentiation, and survival, and its aberrant expression has been implicated in various diseases.

Potential Drug Target

FGF7P6 is a potential drug target due to its central role in cell proliferation and growth. It has been shown to promote the growth and survival of various cell types, including cancer cells, and it has been linked to the development of various diseases, including cancer . Therefore, targeting FGF7P6 may be an effective way to treat these diseases.

FGF7P6 has been shown to play a role in the development and progression of various types of cancer, including breast, ovarian, and colorectal cancers. It has been shown to promote the growth and survival of cancer cells, and it has been linked to the development of resistance to chemotherapy in cancer cells. Therefore, targeting FGF7P6 in cancer therapy may be an effective way to treat these diseases.

Biomarker

FGF7P6 has also been shown to be a potential biomarker for various diseases, including cancer. Its expression has been shown to be associated with the development and progression of cancer, and it has been used as a biomarker for cancer diagnosis and prognosis.

FGF7P6 has been shown to be downregulated in various types of cancer, including breast, ovarian, and colorectal cancers. This suggests that targeting FGF7P6 may be an effective way to treat these cancers, as it has been shown to promote their growth and survival.

FGF7P6 has also been shown to be upregulated in various types of cancer, including neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. This suggests that targeting FGF7P6 in these diseases may be an effective way to treat them, as it has been shown to promote their growth and survival.

Conclusion

FGF7P6 is a potential drug target and biomarker that has been shown to play a crucial role in the development and progression of various diseases, including cancer. Its downregulation has been implicated in the development of these diseases, and its upregulation has been linked to the growth and survival of various cell types. Therefore, targeting FGF7P6 may be an effective way to treat these diseases and improve the quality of life for individuals with these conditions.

Protein Name: Fibroblast Growth Factor 7 Pseudogene 6

The "FGF7P6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FGF7P6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets